PDT Partners’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-49,629
| Closed | -$509K | – | 579 |
|
|
2016
Q3 | $509K | Buy |
49,629
+2,400
| +5% | +$24.6K | 0.03% | 373 |
|
|
2016
Q2 | $617K | Hold |
47,229
| – | – | 0.05% | 311 |
|
|
2016
Q1 | $520K | Hold |
47,229
| – | – | 0.03% | 409 |
|
|
2015
Q4 | $435K | Sell |
47,229
-259,408
| -85% | -$2.39M | 0.06% | 287 |
|
|
2015
Q3 | $2.13M | Buy |
306,637
+57,037
| +23% | +$396K | 0.05% | 410 |
|
|
2015
Q2 | $2.45M | Sell |
249,600
-29,401
| -11% | -$289K | 0.06% | 359 |
|
|
2015
Q1 | $2.47M | Buy |
279,001
+47,601
| +21% | +$422K | 0.06% | 396 |
|
|
2014
Q4 | $2.03M | Buy |
231,400
+14,800
| +7% | +$130K | 0.19% | 115 |
|
|
2014
Q3 | $1.49M | Hold |
216,600
| – | – | 0.04% | 513 |
|
|
2014
Q2 | $1.14M | Hold |
216,600
| – | – | 0.03% | 653 |
|
|
2014
Q1 | $986K | Sell |
216,600
-200
| -0.1% | -$910 | 0.02% | 682 |
|
|
2013
Q4 | $1.09M | Buy |
216,800
+4,700
| +2% | +$23.7K | 0.13% | 223 |
|
|
2013
Q3 | $1.08M | Buy |
212,100
+7,400
| +4% | +$37.5K | 0.03% | 745 |
|
|
2013
Q2 | $1.02M | Buy |
+204,700
| New | +$1.02M | 0.02% | 810 |
|